Latest News about NVO
Recent news which mentions NVO
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
From Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
July 29, 2024
From InvestorPlace
From Motley Fool
From Motley Fool
From Motley Fool
Tickers
NVO
From Motley Fool
Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?
July 27, 2024
From Motley Fool
From Motley Fool
Novo Nordisk Shares Decline Amid Competitive Pressure
July 25, 2024
From Benzinga
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
July 25, 2024
From Benzinga
From InvestorPlace
Beware, Wegovy -- Pfizer Is Working on a Competitor
July 25, 2024
From Motley Fool
3 Fabulous Growth Stocks to Buy and Hold Forever
July 24, 2024
From InvestorPlace
UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
July 24, 2024
From Benzinga
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
From Benzinga
From InvestorPlace
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
July 23, 2024
From Benzinga
Britain's Drug Regulator Approves Novo Nordisk's Weight Loss Drug Wegovy To Cut Heart Disease Risk In Obese Patients
July 23, 2024
From Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
From Motley Fool
Why Hims & Hers Heath Shares Are Surging Today
July 22, 2024
From Benzinga
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
July 22, 2024
From Benzinga
From Benzinga
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
From InvestorPlace
Here's My Top Growth Stock to Buy Right Now
July 20, 2024
From Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
From Motley Fool
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications
July 19, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.